Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol

Bone Marrow Transplantation

Volumn 8, Issue 2, 1991, Pages 99-103

  Carella, A M ^a   Carlier, P ^a   Congiu, A ^a   Occhini, D ^a   Nati, S ^a   Santini, G ^a   Pierluigi, D ^a   Giordano, D ^a   Bacigalupo, A ^a   Damasio, E ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINDESINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROGNOSIS; REMISSION; SURVIVAL; TOXICITY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMAN; MALE; MECHLORETHAMINE; MIDDLE AGE; PREDNISONE; PROCARBAZINE; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 0025814720     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)